Delivery Order SPE2DB20D1047-SPE2DB25FF44U

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,245.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Motegrity 2 mg tablets and has a completion date of December 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,720.73, is for the delivery of Motegrity 2 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a period of performance running through February 26, 2024. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the pharmaceutical product Motegrity 2 mg tablets. The contract has a period of performance through February 16, 2024 and a ceiling value of $2,082.37. The contract is a firm fixed price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award from the Defense Logistics Agency (DLA) is for the delivery of Motegrity 2 mg tablets to the federal government. The $3,096.63 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with no set-aside designation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award is a Delivery Order valued at $3,915.55 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOTEGRITY 2 MG TABLET UU 30S, a prescription medication, with a period of performance through May 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This federal contract award, valued at $7,842.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOTEGRITY 1 MG TABLET UU 30S, a pharmaceutical product, with an ultimate completion date of October 29, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (Contract #SPE2DB22D3401|SPE2DB25FT0WA) from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of MOTEGRITY 2 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $1,878.42 and a period of performance through November 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,366.55 firm-fixed-price delivery order is for the supply of 4565481622 - MOTEGRITY 2 MG TABLET UU 30S, with an ultimate completion date of August 19, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,543.25 firm fixed-price delivery order is for the supply of MOTEGRITY 2 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DX15D3022|SPE2DX23FTWNH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,580.36 firm fixed-price delivery order is for 4560616960 - MOTEGRITY 1 MG TABLET UU 30S, with an ultimate completion date of April 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF44U
    Delivery Order

This is a delivery order contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,901.65, is for the supply of Motegrity 2 mg tablets to support federal healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

The contract does not have a set-aside designation, indicating open competition. As a major supplier of pharmaceutical and medical products to the federal government, Amerisourcebergen plays a critical role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries through its extensive distribution capabilities and contract vehicles with agencies such as the DLA and the Department of Justice Federal Bureau of Investigation.

Generated 5/27/25, 9:51 AM